Comment on Ford et al., 'Sustaining access to antiretroviral therapy in developing countries: lessons from Brazil and Thailand'

Comment

Jeffrey R Stewart. AIDS. 2007 Jul.

. 2007 Jul:21 Suppl 4:S129; author reply S129-30.

doi: 10.1097/01.aids.0000279715.68559.d6.

No abstract available

Comment on

Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K. Ford N, et al. AIDS. 2007 Jul;21 Suppl 4:S21-9. doi: 10.1097/01.aids.0000279703.78685.a6. AIDS. 2007. PMID: 17620749 Review.

The (political) economics of antiretroviral treatment in developing countries.
Nattrass NJ. Nattrass NJ. Trends Microbiol. 2008 Dec;16(12):574-9. doi: 10.1016/j.tim.2008.08.012. Epub 2008 Oct 27. Trends Microbiol. 2008. PMID: 18964022
Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
James JS. James JS. AIDS Treat News. 2001 Feb 28;(361):5-7. AIDS Treat News. 2001. PMID: 12765151
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K. Ford N, et al. AIDS. 2007 Jul;21 Suppl 4:S21-9. doi: 10.1097/01.aids.0000279703.78685.a6. AIDS. 2007. PMID: 17620749 Review.
Access to essential drugs, human rights and global justice.
Shalev C. Shalev C. Monash Bioeth Rev. 2004 Jan;23(1):S56-74. Monash Bioeth Rev. 2004. PMID: 15835024 No abstract available.
TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B. Orsi F, et al. AIDS. 2007 Oct 1;21(15):1997-2003. doi: 10.1097/QAD.0b013e328273bbe4. AIDS. 2007. PMID: 17885289 Review. No abstract available.